Loading…
Chiesi is a global biopharmaceutical group focused on research and development of innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company is a certified B Corp committed to integrating sustainability into its business model to create long-term value for patients, communities, and the environment.
AI named Chiesi in December 2025.